Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
    • Transskriptioner
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Episurf Medical

0,04 SEK

Mindre end 1K følgere

EPIS B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
Sammenligne
-2,89 %
-10,65 %
-0,54 %
+23,41 %
-23,12 %
-49,94 %
-96,97 %
-98,06 %
-98,98 %

Episurf Medical operates in the medical technology industry and focuses on the development and manufacture of individually adapted implants for joint repair. The company's products are aimed at surgeons and healthcare institutions. The business is global with a main presence in Europe, North America and Asia. Episurf Medical was founded in 2008 and is headquartered in Stockholm, Sweden.

Læs mere
Markedsværdi
103,71 mio. SEK
Aktieomsætning
-
Omsætning
13,5 mio.
EBIT %
-428,89 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
10.4
2026

Generalforsamling '26

24.4
2026

Delårsrapport Q1'26

24.8
2026

Delårsrapport Q2'26

Alle
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
Selskabsmeddelelse27.2.2026, 10.45

Change in number of shares and votes in Episurf Medical

Episurf Medical
Pressemeddelelse25.2.2026, 07.30

New US patent approval for Episurf Medical

Episurf Medical
Selskabsmeddelelse24.2.2026, 09.15

The Board of Directors of Episurf has resolved on an issue of Class B shares, convertible debentures and warrants as part of the consideration for the acquisition of real estate assets

Episurf Medical

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse23.2.2026, 15.15

Episurf Medical AB announces outcome of exercise of warrants of series TO14 B

Episurf Medical
Selskabsmeddelelse23.2.2026, 07.30

Members of the Nomination Committee for Episurf Medical's Annual General Meeting 2026

Episurf Medical
Selskabsmeddelelse10.2.2026, 09.40

Episurf Medical announces leadership changes effective from 11 February 2026

Episurf Medical
Selskabsmeddelelse10.2.2026, 08.55

Press release from extraordinary general meeting in Episurf Medical AB (publ)

Episurf Medical
Pressemeddelelse9.2.2026, 07.30

The exercise period for warrants of series TO14 B in Episurf commences today

Episurf Medical
Selskabsmeddelelse6.2.2026, 07.30

Episurf: YEAR-END REPORT 1 JANUARY - 31 DECEMBER 2025

Episurf Medical
Selskabsmeddelelse26.1.2026, 07.00

Episurf acquires properties with an agreed property value of MSEK 897 from KlaraBo

Episurf Medical
Selskabsmeddelelse8.1.2026, 16.50

Notice of Extraordinary General Meeting of Episurf Medical AB (publ)

Episurf Medical
Selskabsmeddelelse8.1.2026, 16.40

Episurf has completed the first closing of the acquired real estate assets, convenes an extraordinary general meeting and announces a board change

Episurf Medical
Selskabsmeddelelse30.12.2025, 13.35

Episurf forms a new strategic business segment through the acquisition of real estate assets. The purchase price of SEK up to 1,147 million is partly paid through shares, convertibles and warrants

Episurf Medical
Pressemeddelelse18.11.2025, 10.45

Update on Episurf Medical's MTP implant

Episurf Medical
Pressemeddelelse4.11.2025, 07.45

Episurf's implants market approved in Singapore

Episurf Medical
Selskabsmeddelelse2.11.2025, 20.30

Board Member Resigns from the Board of Episurf Medical

Episurf Medical
Pressemeddelelse27.10.2025, 13.20

Redeye: Episurf Medical (Q3 review) - Growing the US customer base

Episurf Medical
Selskabsmeddelelse24.10.2025, 06.30

Episurf: Interim Report 1 January - 30 September 2025

Episurf Medical
Pressemeddelelse17.10.2025, 06.45

Episurf: Scientific article on Episealer® Knee with up to 10 years' follow-up published

Episurf Medical
Pressemeddelelse12.10.2025, 20.00

Board Member Resigns from the Board of Episurf Medical

Episurf Medical
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.